ロード中...
Her-2/neu amplification and breast cancer survival: Results from the Shanghai breast cancer study
Her-2/neu is a member of the epidermal growth factor receptor family that has been found to be overexpressed or amplified in ~20-30% of breast cancers. Negative prognosticators and a shortened survival have been shown to be associated with these changes in Her-2/neu, but previous studies have consis...
保存先:
| 出版年: | Oncol Rep |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6519112/ https://ncbi.nlm.nih.gov/pubmed/18425397 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|